PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China; Cardiovascular Research Institute, Wuhan University, Wuhan, China; Hubei Key Laboratory of Cardiology, Wuhan, China.\', \'Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China; Cardiovascular Research Institute, Wuhan University, Wuhan, China; Hubei Key Laboratory of Cardiology, Wuhan, China. Electronic address: wanjun@whu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0024-3205(20)30894-810.1016/j.lfs.2020.118142
?:doi
?:hasPublicationType
?:journal
  • Life sciences
is ?:pmid of
?:pmid
?:pmid
  • 32712300
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.071
?:rankingScore_hIndex
  • 145
is ?:relation_isRelatedTo_publication of
?:title
  • The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all